![]() ![]() She has previously served as a Non-Executive Director of Premier Foods plc and Woodford Patient Capital Trust plc, and as a director of several not-for-profit organisations. She is currently a Non-Executive Director of Theramex Ltd, a pharmaceutical company, Atotech Ltd, a specialty chemicals company, and of Intertek Group plc, the FTSE 100 testing and certification group a position she will step down from in June 2021. Louise has broad experience as a board member. Louise led the transformation of the company through a combination of organic growth and acquisitions, during which its market capitalisation increased from $150m to $4.2bn, before its sale to Boston Scientific in 2019. Louise has a distinguished career in business as a chief executive and board director, working across multiple sectors.įor 15 years Louise was Chief Executive Officer of BTG plc, the international specialist healthcare company. Louise will replace Paul Walker as Chair in July 2021, when he steps down from the Board after eight years in that role, as previously announced. She will join the Nomination and Remuneration committees. Louise is joining the Board today as an independent Non-Executive Director and Chair Designate. ![]() Halma, the FTSE 100 global group of life-saving technology companies, today announces the appointment of Dame Louise Makin as its next Chair. Halma appoints Dame Louise Makin as its next Chair ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |